Fecal occult blood screening in the Minnesota study: role of chance detection of lesions
- PMID: 9326911
- DOI: 10.1093/jnci/89.19.1423
Fecal occult blood screening in the Minnesota study: role of chance detection of lesions
Abstract
Background: In the Minnesota Colon Cancer Control Study, annual fecal occult blood testing reduced mortality from colorectal cancer by at least 33.4%. Some attribute a large part of this reduction to chance detection of cancers by colonoscopies; rehydration of guaiac test slides greatly increased positivity and consequently the number of colonoscopies performed. This study was conducted to determine how much of the reduction resulted from chance detection.
Methods: We used a mathematical model developed by Lang and Ransohoff to estimate the proportion of the 33.4% mortality attainable by chance alone. Applying the model requires the specification of five parameters: duration of follow-up, rate of compliance with fecal occult blood testing, rate of compliance with colonoscopy, positivity rate, and efficacy of colonoscopy in reducing colorectal cancer mortality. We took values for four of the five parameters directly from the Minnesota study. For the fifth parameter, efficacy of colonoscopy, we selected a value of 60%, based on the conclusions of another study. Whereas the Lang-Ransohoff model selects persons for colonoscopy by chance alone, those with bleeding cancers would also be selected by sensitive fecal occult blood testing. We therefore adjusted the result of the Lang-Ransohoff model for this dual detectability.
Results: We found that 16%-25% of the reduction in colorectal cancer deaths effected by fecal occult blood testing in the Minnesota study was due to chance detection; the remainder was due to sensitive detection.
Conclusion: Chance played a minor role in the detection of colorectal cancers by fecal occult blood testing in the Minnesota study.
Comment in
-
On the sensitivity of fecal occult blood test screening for colorectal cancer.J Natl Cancer Inst. 1997 Oct 1;89(19):1392-3. doi: 10.1093/jnci/89.19.1392. J Natl Cancer Inst. 1997. PMID: 9326904 Review. No abstract available.
Similar articles
-
Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?JAMA. 1994 Apr 6;271(13):1011-3. JAMA. 1994. PMID: 8139058
-
Fecal occult blood screening in the Minnesota study: sensitivity of the screening test.J Natl Cancer Inst. 1997 Oct 1;89(19):1440-8. doi: 10.1093/jnci/89.19.1440. J Natl Cancer Inst. 1997. PMID: 9326913
-
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.J Natl Cancer Inst. 1999 Mar 3;91(5):434-7. doi: 10.1093/jnci/91.5.434. J Natl Cancer Inst. 1999. PMID: 10070942
-
Fecal occult blood screening for colorectal cancer.Arch Intern Med. 1995 Dec 11-25;155(22):2389-402. doi: 10.1001/archinte.155.22.2389. Arch Intern Med. 1995. PMID: 7503597 Review.
-
Colorectal cancer screening.World J Gastroenterol. 2006 Nov 14;12(42):6747-50. doi: 10.3748/wjg.v12.i42.6747. World J Gastroenterol. 2006. PMID: 17106920 Free PMC article. Review.
Cited by
-
Screening for colon cancer.Cancer Imaging. 2006 Oct 31;6(Spec No A):S13-21. doi: 10.1102/1470-7330.2006.9026. Cancer Imaging. 2006. PMID: 17114066 Free PMC article.
-
Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.Br J Cancer. 2007 Jan 29;96(2):218-21. doi: 10.1038/sj.bjc.6603534. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211476 Free PMC article.
-
Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.Can J Gastroenterol. 2007 Jun;21(6):379-82. doi: 10.1155/2007/569689. Can J Gastroenterol. 2007. PMID: 17571172 Free PMC article.
-
Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.Gut Liver. 2016 Mar;10(2):204-11. doi: 10.5009/gnl15420. Gut Liver. 2016. PMID: 26934885 Free PMC article. Review.
-
Screening for colorectal cancer using the faecal occult blood test, Hemoccult.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001216. doi: 10.1002/14651858.CD001216.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253456 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical